Rosenson Robert S
Preventive Cardiology Center, Northwestern University, The Feinberg School of Medicine, Galter Pavilion 11-120, 201 East Huron Street, Chicago, IL 60611, USA.
Curr Opin Cardiol. 2005 Jul;20(4):313-7. doi: 10.1097/01.hco.0000168534.15085.5d.
Discuss the contribution of low-density lipoprotein subclass abnormalities to cardiovascular risk among individuals with low high-density lipoprotein cholesterol levels.
Low high-density lipoprotein cholesterol levels are commonly encountered among patients with early onset cardiovascular disease. Most often, a low high-density lipoprotein cholesterol level is not an isolated abnormality, but it is usually associated with a number of other lipoprotein abnormalities. Data from the Framingham Offspring Study demonstrate that among subjects with high-density lipoprotein cholesterol, 1.0 mmol/L (39 mg/dL), low-density lipoprotein particle numbers were considerably higher than indicated by the level of low-density lipoprotein cholesterol because these subjects had excess numbers of small cholesterol-depleted low-density lipoprotein particles. Elevated numbers of low-density lipoprotein particles identify individuals at highest risk for atherosclerotic vascular disease and cardiovascular events.
As high levels of low-density lipoprotein particles are a robust predictor of cardiovascular events, strategies targeted at raising low levels of high-density lipoprotein cholesterol must account for low-density lipoprotein particle interactions.
探讨低密度脂蛋白亚类异常在高密度脂蛋白胆固醇水平较低个体的心血管风险中的作用。
早发心血管疾病患者中常出现高密度脂蛋白胆固醇水平较低的情况。大多数情况下,高密度脂蛋白胆固醇水平低并非孤立的异常,而是通常与许多其他脂蛋白异常相关。弗雷明汉后代研究的数据表明,在高密度脂蛋白胆固醇水平为1.0 mmol/L(39 mg/dL)的受试者中,低密度脂蛋白颗粒数量比低密度脂蛋白胆固醇水平所显示的要高得多,因为这些受试者有过多的小的胆固醇含量低的低密度脂蛋白颗粒。低密度脂蛋白颗粒数量增加表明个体发生动脉粥样硬化性血管疾病和心血管事件的风险最高。
由于高水平的低密度脂蛋白颗粒是心血管事件的有力预测指标,针对提高低水平高密度脂蛋白胆固醇的策略必须考虑低密度脂蛋白颗粒之间的相互作用。